Tuesday, September 26, 2017

Intepirdine fails to treat Alzheimer’s disease in Phase 3 trial

Intepirdine fails to treat Alzheimer’s disease in Phase 3 trial:

Dementia Big
Axovant Sciences today announced that the Phase 3 MINDSET trial of its Alzheimer’s drug intepirdine has failed to bring meaningful improvements in cognition or daily functioning.


http://ift.tt/2y6BQNR

No comments:

Post a Comment